Cystic Fibrosis - Pipeline Review, H2 2018

Publisher Name :
Date: 11-Sep-2018
No. of pages: 435
Inquire Before Buying

Cystic Fibrosis - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis - Pipeline Review, H2 2018, provides an overview of the Cystic Fibrosis (Respiratory) pipeline landscape.

Cystic fibrosis (CF) is an inherited disease that causes mucus to build up and clog some of the body's organs, particularly the lungs and pancreas. Cystic fibrosis affects the cells that produce mucus, sweat and digestive juices.  Symptoms include wheezing, breathlessness, repeated lung infections, inflamed nasal passages or a stuffy nose and severe constipation. Risk factors include family history and race (Northern European ancestry). Treatment includes antibiotics, mucus-thinning, bronchodilators and oral pancreatic enzymes.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Cystic Fibrosis - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Cystic Fibrosis (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Cystic Fibrosis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cystic Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 1, 5, 29, 27, 60 and 30 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical, Discovery and Unknown stages comprises 2, 1, 10, 9 and 1 molecules, respectively.

Cystic Fibrosis (Respiratory) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Cystic Fibrosis (Respiratory).

- The pipeline guide reviews pipeline therapeutics for Cystic Fibrosis (Respiratory) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Cystic Fibrosis (Respiratory) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Cystic Fibrosis (Respiratory) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Cystic Fibrosis (Respiratory)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Cystic Fibrosis (Respiratory).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Cystic Fibrosis (Respiratory) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Cystic Fibrosis - Pipeline Review, H2 2018

Table of Contents
Table of Contents 2
Introduction 6
Cystic Fibrosis - Overview 7
Cystic Fibrosis - Therapeutics Development 8
Cystic Fibrosis - Therapeutics Assessment 29
Cystic Fibrosis - Companies Involved in Therapeutics Development 41
Cystic Fibrosis - Drug Profiles 76
Cystic Fibrosis - Dormant Projects 395
Cystic Fibrosis - Discontinued Products 403
Cystic Fibrosis - Product Development Milestones 404
Appendix 417

List of Tables
Number of Products under Development for Cystic Fibrosis, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Cystic Fibrosis - Pipeline by 4D Molecular Therapeutics Inc, H2 2018
Cystic Fibrosis - Pipeline by Advanced Inhalation Therapies (AIT) Ltd, H2 2018
Cystic Fibrosis - Pipeline by Aeolus Pharmaceuticals Inc, H2 2018
Cystic Fibrosis - Pipeline by AGILeBiotics BV, H2 2018
Cystic Fibrosis - Pipeline by Alaxia SAS, H2 2018
Cystic Fibrosis - Pipeline by AlgiPharma AS, H2 2018
Cystic Fibrosis - Pipeline by AmpliPhi Biosciences Corp, H2 2018
Cystic Fibrosis - Pipeline by Antabio SAS, H2 2018
Cystic Fibrosis - Pipeline by Arch Biopartners Inc, H2 2018
Cystic Fibrosis - Pipeline by Arcturus Therapeutics Ltd, H2 2018
Cystic Fibrosis - Pipeline by Aridis Pharmaceuticals Inc, H2 2018
Cystic Fibrosis - Pipeline by Arrowhead Pharmaceuticals Inc, H2 2018
Cystic Fibrosis - Pipeline by AstraZeneca Plc, H2 2018
Cystic Fibrosis - Pipeline by Boehringer Ingelheim GmbH, H2 2018
Cystic Fibrosis - Pipeline by Calithera Biosciences Inc, H2 2018
Cystic Fibrosis - Pipeline by Catabasis Pharmaceuticals Inc, H2 2018
Cystic Fibrosis - Pipeline by Celtaxsys Inc, H2 2018
Cystic Fibrosis - Pipeline by Chiesi Farmaceutici SpA, H2 2018
Cystic Fibrosis - Pipeline by Cilian AG, H2 2018
Cystic Fibrosis - Pipeline by CRISPR Therapeutics, H2 2018
Cystic Fibrosis - Pipeline by Cyclacel Pharmaceuticals Inc, H2 2018
Cystic Fibrosis - Pipeline by Cyclenium Pharma Inc, H2 2018
Cystic Fibrosis - Pipeline by DiscoveryBiomed Inc, H2 2018
Cystic Fibrosis - Pipeline by Editas Medicine Inc, H2 2018
Cystic Fibrosis - Pipeline by Eloxx Pharmaceuticals Inc, H2 2018
Cystic Fibrosis - Pipeline by Enterprise Therapeutics Ltd, H2 2018
Cystic Fibrosis - Pipeline by Errant Gene Therapeutics LLC, H2 2018
Cystic Fibrosis - Pipeline by ethris GmbH, H2 2018
Cystic Fibrosis - Pipeline by Evaxion Biotech ApS, H2 2018
Cystic Fibrosis - Pipeline by Galapagos NV, H2 2018
Cystic Fibrosis - Pipeline by Generation Bio Corp, H2 2018
Cystic Fibrosis - Pipeline by Grifols SA, H2 2018
Cystic Fibrosis - Pipeline by Grupo Praxis Pharmaceutical SA, H2 2018
Cystic Fibrosis - Pipeline by Helperby Therapeutics Group Ltd, H2 2018
Cystic Fibrosis - Pipeline by Homology Medicines, Inc., H2 2018
Cystic Fibrosis - Pipeline by Horizon Pharma Plc, H2 2018
Cystic Fibrosis - Pipeline by ID Pharma Co Ltd, H2 2018
Cystic Fibrosis - Pipeline by Idorsia Pharmaceutical Ltd, H2 2018
Cystic Fibrosis - Pipeline by Immun System IMS AB, H2 2018
Cystic Fibrosis - Pipeline by Insmed Inc, H2 2018
Cystic Fibrosis - Pipeline by Invion Ltd, H2 2018
Cystic Fibrosis - Pipeline by Ionis Pharmaceuticals Inc, H2 2018
Cystic Fibrosis - Pipeline by JHL Biotech Inc, H2 2018
Cystic Fibrosis - Pipeline by Johnson & Johnson, H2 2018
Cystic Fibrosis - Pipeline by Kamada Ltd, H2 2018
Cystic Fibrosis - Pipeline by Kyorin Pharmaceutical Co Ltd, H2 2018
Cystic Fibrosis - Pipeline by Lamellar Biomedical Ltd, H2 2018
Cystic Fibrosis - Pipeline by Laurent Pharmaceuticals Inc, H2 2018
Cystic Fibrosis - Pipeline by Lexicon Pharmaceuticals Inc, H2 2018
Cystic Fibrosis - Pipeline by Microbion Corp, H2 2018
Cystic Fibrosis - Pipeline by Novabiotics Ltd, H2 2018

List of Figures
Number of Products under Development for Cystic Fibrosis, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Number of Products by Top 10 Targets, H2 2018
Number of Products by Stage and Top 10 Targets, H2 2018
Number of Products by Top 10 Mechanism of Actions, H2 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Top 10 Molecule Types, H2 2018
Number of Products by Stage and Top 10 Molecule Types, H2 2018
  • Global Infant Ventilators Market Insights, Forecast to 2025
    Published: 14-Nov-2018        Price: US 4900 Onwards        Pages: 95
    This report studies the global market size of Infant Ventilators in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Infant Ventilators in these regions. This research report categorizes the global Infant Ventilators market by top players/brands, region, type and end user. This report also studies the global Infant Ventilators market status, competition landscape, market share, growth rate, future trends,......
  • Global Emergency Ventilator Market Insights, Forecast to 2025
    Published: 14-Nov-2018        Price: US 4900 Onwards        Pages: 97
    This report studies the global market size of Emergency Ventilator in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Emergency Ventilator in these regions. This research report categorizes the global Emergency Ventilator market by top players/brands, region, type and end user. This report also studies the global Emergency Ventilator market status, competition landscape, market share, growth rate, future......
  • Global End-expiratory CO2 Detector Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 3900 Onwards        Pages: 112
    This report researches the worldwide End-expiratory CO2 Detector market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global End-expiratory CO2 Detector breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales ch......
  • Global Sleep Apnea Diagnostic and Therapeutic Devices Market Data Survey Report 2025
    Published: 10-Nov-2018        Price: US 1500 Onwards        Pages: 84
    Summary The global Sleep Apnea Diagnostic and Therapeutic Devices market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on ma......
  • Global Ventilator Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 09-Nov-2018        Price: US 3480 Onwards        Pages: 119
    Ventilators have advanced from basic or simple machines to complex, electronic, micro-processing engines with improved capabilities and options/features. Scope of the Report: Factors such as increasing number of preterm births, rapid growth in the geriatric population, rising prevalence of respiratory diseases, and rising number of ICU beds are expected to drive the growth of the ventilators market during the forecast period. The worldwide market fo......
  • Global Ventilator Market Research Report 2018
    Published: 08-Nov-2018        Price: US 2900 Onwards        Pages: 129
    This report studies the global Ventilator market status and forecast, categorizes the global Ventilator market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Resmed - Medtronic - BD (Carefusion) - Philips Healthcare - GE Healthcare......
  • Global Sleep Apnea Diagnostic and Therapeutic Devices Market Research Report 2018
    Published: 06-Nov-2018        Price: US 2900 Onwards        Pages: 121
    This report studies the global Sleep Apnea Diagnostic and Therapeutic Devices market status and forecast, categorizes the global Sleep Apnea Diagnostic and Therapeutic Devices market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - ResMed - Phlips Respiro......
  • Global Medical Oxygen Cylinder Market Research Report 2018
    Published: 05-Nov-2018        Price: US 2900 Onwards        Pages: 112
    This report studies the global Medical Oxygen Cylinder market status and forecast, categorizes the global Medical Oxygen Cylinder market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Luxfer Gas Cylinders - Cramer Decker Medical - Catalina Cylind......
  • Global Oxygen Inhaler Market Research Report 2018
    Published: 05-Nov-2018        Price: US 2900 Onwards        Pages: 114
    This report studies the global Oxygen Inhaler market status and forecast, categorizes the global Oxygen Inhaler market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Vicks - Drive Medical - Benzedrex - Asthmanefrin - Briggs Healthca......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs